Literature DB >> 12761728

Side effects of therapy for chronic hepatitis C.

Mark W Russo1, Michael W Fried.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761728     DOI: 10.1016/s0016-5085(03)00394-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  87 in total

1.  Review.

Authors:  Gloria Taliani; Elisa Biliotti
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-08

2.  Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C.

Authors:  Robin Midian-Singh; Suresh Alagugurusamy; Radeshyam Agrawal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-08

3.  De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection.

Authors:  Jose L Tovar; Maria Buti; Alfonso Segarra; Joaquim Majó; Rafael Esteban
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

4.  Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin.

Authors:  A H Lashin; Y A Shaheen; M A Metwally; H M El-Feky; M F Hegab; S M Abbas
Journal:  Indian J Gastroenterol       Date:  2013-05-29

5.  Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C.

Authors:  Toshihiro Kawaguchi; Tatsuya Ide; Hironori Koga; Reiichiro Kondo; Ichiro Miyajima; Teruko Arinaga-Hino; Reiichiro Kuwahara; Keisuke Amano; Takashi Niizeki; Masahito Nakano; Ryoko Kuromatsu; Takuji Torimura
Journal:  Clin J Gastroenterol       Date:  2017-10-29

6.  Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C.

Authors:  Motoyuki Kohjima; Miho Kurokawa; Munechika Enjoji; Tsuyoshi Yoshimoto; Tsukasa Nakamura; Tomoko Ohashi; Kunitaka Fukuizumi; Naohiko Harada; Yusuke Murata; Kazuhisa Matsunaga; Masaki Kato; Kazuhiro Kotoh; Makoto Nakamuta
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

Review 7.  Hepatitis C and interferon induced thyroiditis.

Authors:  Yaron Tomer
Journal:  J Autoimmun       Date:  2010-05       Impact factor: 7.094

8.  Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism.

Authors:  Tomoki Ryu; Yuko Takami; Norifumi Tsutsumi; Masaki Tateishi; Kazuhiro Mikagi; Yoshiyuki Wada; Hideki Saitsu
Journal:  Surg Today       Date:  2016-08-30       Impact factor: 2.549

Review 9.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 10.  Hepatitis C virus infection: Are there still specific problems with genotype 3?

Authors:  Claire Gondeau; Georges Philippe Pageaux; Dominique Larrey
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.